Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model-Reference-Cited by-同舟云学术

Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model

Published:2021-09 Issue:3 Volume:74 Page:1395-1410
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Zhao Yue¹^ORCID,Wang Jiaxu²^ORCID,Liu Wai Nam¹,Fong Shin Yie¹,Shuen Timothy Wai Ho³,Liu Min¹,Harden Sarah¹,Tan Sue Yee¹,Cheng Jia Ying¹,Tan Wilson Wei Sheng¹,Chan Jerry Kok Yen⁴⁵,Chee Cheng Ean⁶,Lee Guan Huei⁷,Toh Han Chong³,Lim Seng Gee⁷^ORCID,Wan Yue²^ORCID,Chen Qingfeng¹⁸

Affiliation:

1. Institute of Molecular and Cell Biology Agency for Science, Technology and Research Singapore

2. Genome Institute of Singapore Agency for Science, Technology and Research Singapore

3. Division of Medical Oncology National Cancer Centre Singapore Singapore

4. Department of Reproductive Medicine Kandang Kerbau Women’s and Children's Hospital Singapore

5. Experimental Fetal Medicine Group Yong Loo Lin School of Medicine National University of Singapore Singapore

6. Department of Hematology‐Oncology National University Cancer Institute Singapore

7. Division of Gastroenterology and Hepatology National University Health System Singapore

8. Department of Microbiology and Immunology Yong Loo Lin School of Medicine National University of Singapore Singapore

Funder

Agency for Science, Technology and Research

National Medical Research Council

National Research Foundation Singapore

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31812

Reference52 articles.

1. Hepatocellular carcinoma;Villanueva A;N Engl J Med,2019

2. Liver carcinogenesis by FOS‐dependent inflammation and cholesterol dysregulation;Bakiri L;J Exp Med,2017

3. Inflammation‐induced IgA+ cells dismantle anti‐liver cancer immunity;Shalapour S;Nature,2017

4. Targeting inflammation in cancer prevention and therapy;Todoric J;Cancer Prev Res,2016

5. Interleukin‐8 induces expression of FOXC1 to promote transactivation of CXCR1 and CCL2 in hepatocellular carcinoma cell lines and formation of metastases in mice;Huang W;Gastroenterology,2015

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between TIGIT expression on T cells and the prognosis of patients with hepatocellular carcinoma;BMC Cancer;2024-09-09

2. Interleukin‐33 and liver natural killer cells: A novel perspective on antitumor activity in liver fibrosis;Hepatology Research;2024-08-12

3. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

4. Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-07-15

5. KLHL21 suppresses gastric tumourigenesis via maintaining STAT3 signalling equilibrium in stomach homoeostasis;Gut;2024-07-05